Man Collapses During Trump’s Oval Office Obesity Drug Announcement
During a Thursday Oval Office press conference, a man collapsed behind President Donald Trump as the administration announced efforts to expand coverage and cut prices for popular obesity treatments Zepbound and Wegovy.
Officials quickly assisted the man, with Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz supporting his head as he was lowered to the floor. The press was promptly removed from the room. The cause of the collapse remains unclear.
White House press secretary Karoline Leavitt said, "During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly."
Leavitt confirmed the man was a guest of one of the health care companies present, Eli Lilly and Novo Nordisk. President Trump later stated the individual felt lightheaded but is now fine. The man did not return to the event.
Approximately an hour after the incident, Trump resumed the weight-loss drug event. He announced a new deal with Eli Lilly and Novo Nordisk aimed at expanding Medicare coverage and lowering costs for the obesity medications.
Summary
During a White House announcement on obesity drug coverage, a man fainted but recovered quickly; President Trump then resumed the event and shared a new Medicare drug pricing deal.